Rheumatoid Arthritis
From the Journals
RA precision medicine using synovial biopsy ‘remains elusive’
Histologic analysis did not sufficiently predict treatment response to certain medications, but gene expression and transcriptome analysis methods...
News from the FDA/CDC
Approximately 20% of U.S. adults are diagnosed with arthritis
New data show disproportionate arthritis prevalence among women, veterans, non-Hispanic White individuals, and those aged 45 years and older.
From the Journals
Abatacept, certolizumab: Best biologics in early RA
The study was the first head-to-head comparison of multiple biologics plus methotrexate vs. active conventional DMARDs plus steroid bridging for...
From the Journals
Biomarkers may help women with RA to decide on medications in pregnancy
Researchers find differences in gene expression before pregnancy that could help women with rheumatoid arthritis choose to stop or continue...
From the Journals
Anemia, iron deficit common in rheumatic disease pregnancy
Low maternal levels of hemoglobin and serum ferritin in pregnancy were associated with adverse infant outcomes.
Conference Coverage
Are women and men with rheumatism treated equally?
Compared with men, women receive a diagnosis of rheumatic disease much later and are treated more poorly, research suggests.
News from the FDA/CDC
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Feature
Are cellular therapies the future of autoimmune disease?
Promising results from small case studies and early clinical trials hint at the potential of CAR T-cell therapy to treat – and possibly cure –...
Conference Coverage
Patients with rheumatism have premature immune system aging
Researchers have studied how the T-cell aging process translates into metabolic reprogramming of the T cells in patients with rheumatoid arthritis...
From the Journals
Extra-articular RA manifestations are in decline, but mortality is still a problem
The incidence of nonsevere extra-articular manifestations of RA decreased over time, likely because of a reduced incidence of rheumatoid nodules...